DeepKinase

Painting the Future:
Beyond Traditional Boundaries in Proteomics

Tailored proteomics for the biopharmaceutical industry. Dive deeper, move faster — exceptional support, unparalleled affordability.

Get Started

Power of 0.1%:
Beyond Serine and Threonine in Deep Phosphoproteomics

DeepKinase’s DoTK technology elevates phosphotyrosine (pY) from its rare occurrence to a centerpiece of phosphoproteomics, uncovering pivotal signaling pathways overlooked by traditional pS/pT analyses. As the exclusive provider of this cutting-edge approach, we offer unparalleled insights into cellular mechanisms, advancing the discovery of novel therapeutic targets and biomarkers. Our focus on the ‘power of 0.1%’—pY’s subtle yet significant presence—empowers researchers globally, unlocking new dimensions in disease understanding and drug development.

Get Started

Erupt with Insights:
Beyond Volcano Plots in TPD Proteomics

Accurate quantitative proteomics transcends traditional analyses to become the cornerstone of Targeted Protein Degradation (TPD) drug development. At DeepKinase, we navigate you beyond the basics—from tailored experiment design to the selection of optimal MS technologies and comprehensive data interpretation. Our expertise in identifying both target and off-target effects equips you with the insights needed to rapidly innovate with next-generation degraders, ensuring your path in this emerging field is both swift and secure.

Get Started

Mark What Matters:
Beyond Binary Mutations in Biomarker Discovery

Biomarkers are the compass of successful drug development, yet binary genomic mutations often fall short in predictive power and discovery. DeepKinase revolutionizes biomarker discovery with a holistic approach to the proteome and functional proteomics. By integrating analyses across multiple tissues and dimensions in a single sweep, we illuminate the landscape of actionable biomarkers, enabling a deeper understanding and more precise targeting in your drug development journey.

Get Started